Agios Pharmaceuticals | AGIO - إيرادات الفوائد





إيرادات الفوائد تغيير تاريخ
AbbVie USD 72M 13M 2026-03
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Arrowhead Research USD 16.93M 66K 2026-06
Astellas Pharma JPY 4.12B 2.94B 2024-03
AstraZeneca USD 80M 7M 2026-06
Bayer EUR 169M 39M 2025-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Exelixis USD 14.21M 1.92M 2026-06
Gilead Sciences USD 95M 0 2026-03
GlaxoSmithKline GBP 22M 96M 2026-03
Incyte USD 38.12M 4.43M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Merck USD 35M 34M 2026-03
Moderna USD 72M 2M 2026-03
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD -0.04 115M 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sarepta Therapeutics USD 7M 1.74M 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06